3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 3
2
Phase 2
2
Phase 1/2
2
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
13
Head and Neck Neoplasms
8
Breast Neoplasms
8
Nasopharyngeal Carcinoma
6
Uterine Cervical Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
4
Oropharyngeal Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Glioma
3
Carcinoma, Squamous Cell
3
Sarcoma, Ewing
2
Sarcoma
2
Rectal Neoplasms
2
Nasopharyngeal Neoplasms
2
Mesothelioma, Malignant
2
Meningeal Carcinomatosis
2
Glioblastoma
2
Wilms Tumor
1
Virus Diseases
1
Tumor Virus Infections
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Stage IA Uterine Sarcoma
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Interventions
Magnetic Resonance Spectroscopy
6
Temozolomide
3
Radiotherapy
3
Magnetic Resonance Imaging
3
Yoga
2
Surgical Procedures, Operative
2
Gadolinium DTPA
2
Biopsy
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
gallium Ga 68 dotatate
1
gadobutrol
1
gadobenic acid
1
fluorodopa F 18
1
alovudine
1
Vincristine
1
Surveys and Questionnaires
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
O(6)-benzylguanine
1
Neuropsychological Tests
1
Mind-Body Therapies
1
Methotrexate
1
Meditation
1
Heart Rate
1
Gelclair
1
Fluorescein
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Astrocytoma
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT02039778
2017-06-05
STRONG
Beth Israel Medical Center
Phase NA
Terminated
4 enrolled
8 charts